GALIERO, RAFFAELE
 Distribuzione geografica
Continente #
EU - Europa 3.044
AS - Asia 1.266
NA - Nord America 650
SA - Sud America 192
AF - Africa 11
Totale 5.163
Nazione #
RU - Federazione Russa 2.536
US - Stati Uniti d'America 630
SG - Singapore 433
CN - Cina 323
HK - Hong Kong 199
IT - Italia 198
BR - Brasile 163
IE - Irlanda 121
KR - Corea 81
VN - Vietnam 80
DE - Germania 64
IN - India 62
JP - Giappone 23
GB - Regno Unito 21
FR - Francia 19
ID - Indonesia 11
AT - Austria 10
FI - Finlandia 10
MX - Messico 10
PL - Polonia 9
AR - Argentina 8
NL - Olanda 8
AE - Emirati Arabi Uniti 7
CA - Canada 6
CO - Colombia 6
CZ - Repubblica Ceca 6
PK - Pakistan 6
TR - Turchia 6
LT - Lituania 5
SE - Svezia 5
UA - Ucraina 5
VE - Venezuela 5
EC - Ecuador 4
ES - Italia 4
IL - Israele 4
MA - Marocco 4
BD - Bangladesh 3
BE - Belgio 3
CH - Svizzera 3
IQ - Iraq 3
IR - Iran 3
PT - Portogallo 3
ZA - Sudafrica 3
AZ - Azerbaigian 2
BO - Bolivia 2
EG - Egitto 2
GE - Georgia 2
GR - Grecia 2
JO - Giordania 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
MO - Macao, regione amministrativa speciale della Cina 2
PE - Perù 2
RO - Romania 2
RS - Serbia 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DK - Danimarca 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
JM - Giamaica 1
LB - Libano 1
LV - Lettonia 1
MY - Malesia 1
NO - Norvegia 1
PY - Paraguay 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TW - Taiwan 1
UY - Uruguay 1
Totale 5.163
Città #
Moscow 897
Singapore 216
Hong Kong 198
Santa Clara 121
Dublin 115
Hefei 101
The Dalles 84
Seoul 81
Naples 72
New York 49
Bengaluru 48
Ashburn 44
Chandler 43
Munich 34
Beijing 31
Ho Chi Minh City 31
Dallas 20
São Paulo 18
Los Angeles 15
Hanoi 13
Salerno 9
Amsterdam 8
Falkenstein 8
Belo Horizonte 7
Brooklyn 7
Liveri 7
Atlanta 6
Bexley 6
Boardman 6
Cambridge 6
Florence 6
Milan 6
Princeton 6
Roxbury 6
Boston 5
Brno 5
Ercolano 5
Frankfurt am Main 5
Helsinki 5
Lahore 5
Nuremberg 5
Stockholm 5
Vienna 5
Chennai 4
Guarulhos 4
Istanbul 4
Paris 4
Pelotas 4
Rio de Janeiro 4
San Francisco 4
Warsaw 4
Biên Hòa 3
Boydton 3
Brasília 3
Bremen 3
Brussels 3
Campinas 3
Chicago 3
Da Nang 3
Denver 3
Haiphong 3
Lappeenranta 3
London 3
Mexico City 3
Mumbai 3
Olbia 3
Porto Alegre 3
Roubaix 3
Shenzhen 3
Tel Aviv 3
Terzigno 3
Toronto 3
Wroclaw 3
Zurich 3
Amman 2
Andria 2
Athens 2
Avellino 2
Baghdad 2
Baku 2
Banda Aceh 2
Belgrade 2
Bishkek 2
Bogotá 2
Bắc Giang 2
Bắc Ninh 2
Cagliari 2
Camden 2
Can Tho 2
Casablanca 2
Changsha 2
Crispano 2
Dhaka 2
Ecatepec 2
Francisco Morato 2
Guastalla 2
Guayaquil 2
Hanover 2
Itaquaquecetuba 2
Jacksonville 2
Totale 2.523
Nome #
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 160
Cardiac Hypertrophy: from Pathophysiological Mechanisms to Heart Failure Development 154
ULTRASOUND TIPS IN THE LUNG CANCER DIAGNOSIS: A PILOT STUDY 140
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes 135
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 132
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes 129
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options 128
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options 126
Comment on: Effect of Vitamin D supplementation in patients with liver cirrhosis having spontaneous bacterial peritonitis: a randomized controlled study 126
GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives 122
Comment on: Warfarin adherence and anticoagulation control in atrial fibrillation patients-a systematic review 118
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 117
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 116
An Update on Betrixaban, the Challenging Anticoagulant Agent for Extended Venous Thromboembolism Prophylaxis 116
Liver Involvement in Patients With Systemic Sclerosis: Role of Transient Elastography in the Assessment of Hepatic Fibrosis and Steatosis 116
Left bundle branch pacing and cardiac remodeling in HF patients with type 2 diabetes mellitus: epigenetic pathways and clinical outcomes 114
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial 109
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 107
CURRENT HEPATOCELLULAR CARCINOMA SYSTEMIC PHARMACOLOGICAL TREATMENT OPTIONS 107
EFFICACY OF COVID-19 VACCINATION IN PATIENTS WITH IMMUNE SYSTEM DISORDERS AND CANCER 104
Diabetic Gastroparesis: Navigating Pathophysiology and Nutritional Interventions 103
Sex-difference of multifactorial intervention on cardiovascular and mortality risk in DKD: post-hoc analysis of a randomised clinical trial 102
Effects of Metformin in Heart Failure: From Pathophysiological Rationale to Clinical Evidence 102
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease 102
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy 102
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications 102
Advances in the Insulin-Heart Axis: Current Therapies and Future Directions 100
Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies 100
ULTRASOUND TIPS IN THE LUNG CANCER DIAGNOSIS: A PILOT STUDY 98
Cardiovascular Benefits from Gliflozins: Effects on Endothelial Function 97
Polypharmacy and major adverse events in atrial fibrillation 97
Changes in clinical scenarios, management, and perspectives of patients with chronic hepatitis C after viral clearance by direct-acting antivirals 95
Optimizing Anticoagulation Management in Atrial Fibrillation: Beyond the Guidelines. How and for Whom? 94
null 93
Modern Challenges in Type 2 Diabetes: Balancing New Medications with Multifactorial Care 92
Advances in Pharmacological Approaches for Managing Hypercholesterolemia: A Comprehensive Overview of Novel Treatments 92
Late Hepatocellular Carcinoma Occurrence in Patients Achieving Sustained Virological Response After Direct-Acting Antiviral Therapy: A Matter of Follow-Up or Something Else? 91
The Significance of Statin-Associated Muscle Symptoms and Its Impact on Patient Adherence and Outcomes 91
Predictive Value of Fatty Liver Index for Long-Term Cardiovascular Events in Patients Receiving Liver Transplantation: The COLT Study 90
Assessment of the Effectiveness of Ticagrelor Preloading in Mitigating Periprocedural Myocardial Injury Among Non-ST Elevation Myocardial Infarction Patients Opting for an Early Invasive Approach 87
NerveCheck master to screen patients with type 1 or type 2 diabetes for peripheral and cardiac autonomic neuropathy 87
The impact of new onset diabetes on cardiovascular risks in orthotopic liver transplant recipients: findings from the COLT study 82
The Role of Neuropathy Screening Tools in Patients Affected by Fibromyalgia 79
The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms 76
Insulin–Heart Axis: Bridging Physiology to Insulin Resistance 76
Saxagliptin/dapagliflozin is non‐inferior to insulin glargine in terms of β‐cell function in subjects with latent autoimmune diabetes in adults: A 12‐month, randomized, comparator‐controlled pilot study 75
The Role of Lung Ultrasound in SARS-CoV-19 Pneumonia Management 75
Impact of Gliflozins on Right Heart Remodeling in Italian Patients with Type 2 Diabetes and Heart Failure: Results from the GLISCAR Real-World Study 64
Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations 61
Remdesivir treatment and clinical outcome in non-severe hospitalized COVID-19 patients: a propensity score matching multicenter Italian hospital experience 60
Does a strict glycemic control during acute coronary syndrome play a cardioprotective effect? Pathophysiology and clinical evidence 59
Impact of empagliflozin as add-on to metformin vs metformin continuation on MASLD progression in type 2 diabetes: The IMAGIN Study 39
Totale 5.239
Categoria #
all - tutte 16.943
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.943


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202246 1 0 0 2 2 0 2 1 9 1 8 20
2022/2023221 11 12 4 10 27 11 5 8 105 10 7 11
2023/2024276 26 13 9 24 51 45 8 9 7 25 26 33
2024/2025984 4 14 3 24 156 98 126 93 164 105 89 108
2025/20263.712 251 308 244 147 407 2.355 0 0 0 0 0 0
Totale 5.239